{
  "retracted": false,
  "timestamp": 1548633600000,
  "updates": [
    {
      "timestamp": 1580172045276,
      "identifier": {
        "doi": "10.1186/s12931-019-0985-2"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1186/s12931-018-0916-7"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease: a Spanish National Healthcare System perspective"
}
